By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

ChenGuang Biotech Group Co., Ltd. (300138.SZ)

SHZ Currency in CNY
¥13.82
+¥0.62
+4.70%
Last Update: 8 Jul 2025, 07:04
¥6.88B
Market Cap
39.46
P/E Ratio (TTM)
0.94%
Forward Dividend Yield
¥6.91 - ¥14.19
52 Week Range

300138.SZ Stock Price Chart

Explore ChenGuang Biotech Group Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300138.SZ price movements and trends.

There is nothing to show.

300138.SZ Company Profile

Discover essential business fundamentals and corporate details for ChenGuang Biotech Group Co., Ltd. (300138.SZ) to support your stock research and investment decisions.

Sector

Consumer Defensive

Industry

Agricultural Farm Products

IPO Date

5 Nov 2010

Employees

1.87K

CEO

Qingguo Lu

Description

ChenGuang Biotech Group Co., Ltd. develops and produces natural colors, spice extracts and essential oils, nutritional and pharmaceutical extracts, and oils and protein. The company offers natural colors, including paprika oleoresin, marigold oleoresin, and turmeric; spice extracts and essential oils, such as capsicum oleoresin, sichuan pepper oil, pepper oleoresin, ginger extract, and cumin oil; lutein, lycopene, grape seed extract, curcumin, inulin, stevioside, and green coffee bean extracts; and grape seed oil, walnut oil, safflower seed oil, flaxseed oil, cottonseed oil, natural lutein, and dephenolized cottonseed protein products. Its products are primarily used in food, cosmetics, baking, beverages, health care, and feed industries. The company operates in Europe; the Americas; Australia; China, Russia, Japan, Korea, and other countries in Asia; and Africa. ChenGuang Biotech Group Co., Ltd. was incorporated in 2000 and is based in Quzhou, China.

300138.SZ Financial Timeline

Browse a chronological timeline of ChenGuang Biotech Group Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Dividend declared on 16 May 2025

A dividend of ¥0.13 per share was announced, adjusted to ¥0.13. The dividend was paid on 16 May 2025.

Earnings released on 25 Apr 2025

EPS came in at ¥0.23 surpassing the estimated ¥0.22 by +4.55%, while revenue for the quarter reached ¥1.77B.

Earnings released on 7 Apr 2025

EPS came in at ¥0.06 surpassing the estimated -¥0.12 by +150.00%, while revenue for the quarter reached ¥1.72B.

Earnings released on 25 Oct 2024

EPS came in at -¥0.07 falling short of the estimated ¥0.11 by -163.64%, while revenue for the quarter reached ¥1.73B.

Earnings released on 26 Aug 2024

EPS came in at ¥0.12, while revenue for the quarter reached ¥1.75B.

Dividend declared on 13 Jun 2024

A dividend of ¥0.13 per share was announced, adjusted to ¥0.13. The dividend was paid on 13 Jun 2024.

Earnings released on 24 Apr 2024

EPS came in at ¥0.08, while revenue for the quarter reached ¥1.73B.

Earnings released on 2 Feb 2024

EPS came in at ¥0.16 falling short of the estimated ¥0.19 by -15.79%, while revenue for the quarter reached ¥1.70B, missing expectations by -1.25%.

Earnings released on 23 Oct 2023

EPS came in at ¥0.19 falling short of the estimated ¥0.25 by -24.12%, while revenue for the quarter reached ¥1.50B, missing expectations by -28.37%.

Earnings released on 13 Aug 2023

EPS came in at ¥0.31 falling short of the estimated ¥0.42 by -26.19%, while revenue for the quarter reached ¥1.85B, missing expectations by -0.01%.

Dividend declared on 17 May 2023

A dividend of ¥0.16 per share was announced, adjusted to ¥0.16. The dividend was paid on 17 May 2023.

Earnings released on 25 Apr 2023

EPS came in at ¥0.25 matching the estimated ¥0.25, while revenue for the quarter reached ¥1.82B, meeting expectations.

Earnings released on 28 Feb 2023

EPS came in at ¥0.19 falling short of the estimated ¥0.20 by -5.00%, while revenue for the quarter reached ¥1.50B, missing expectations by -38.93%.

Earnings released on 26 Oct 2022

EPS came in at ¥0.18 falling short of the estimated ¥0.18 by -0.50%, while revenue for the quarter reached ¥1.57B, meeting expectations.

Earnings released on 22 Aug 2022

EPS came in at ¥0.25 surpassing the estimated ¥0.22 by +13.64%, while revenue for the quarter reached ¥1.64B, beating expectations by +31.36%.

Dividend declared on 1 Jun 2022

A dividend of ¥0.13 per share was announced, adjusted to ¥0.13. The dividend was paid on 1 Jun 2022.

Earnings released on 25 Apr 2022

EPS came in at ¥0.20 falling short of the estimated ¥0.21 by -4.76%, while revenue for the quarter reached ¥1.58B, missing expectations by 0.00%.

Earnings released on 28 Mar 2022

EPS came in at ¥0.18 surpassing the estimated ¥0.15 by +20.00%, while revenue for the quarter reached ¥1.67B, beating expectations by +0.16%.

Earnings released on 25 Oct 2021

EPS came in at ¥0.13 matching the estimated ¥0.13, while revenue for the quarter reached ¥1.11B.

Earnings released on 23 Aug 2021

EPS came in at ¥0.23 matching the estimated ¥0.23, while revenue for the quarter reached ¥1.09B.

Earnings released on 26 Apr 2021

EPS came in at ¥0.15, while revenue for the quarter reached ¥1.01B.

Dividend declared on 22 Apr 2021

A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 22 Apr 2021.

Earnings released on 27 Feb 2021

EPS came in at ¥0.11, while revenue for the quarter reached ¥1.20B.

Earnings released on 26 Oct 2020

EPS came in at ¥0.11, while revenue for the quarter reached ¥882.04M.

Earnings released on 25 Aug 2020

EPS came in at ¥0.20, while revenue for the quarter reached ¥1.09B.

300138.SZ Stock Performance

Access detailed 300138.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
300138.SZ
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
300138.SZ
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More